SCHEMBL21708736

SCHEMBL21708736

CCCC(F)OC(=O)C(C)(C)C(C[N+](=O)[O-])c1ccccc1Cl

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
CYP3A4 P08684 1/20 0.38
GAA P10253 1/20 0.34
CNR1 P21554 1/20 0.33
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
CASP1 P29466 1/20 0.33
PRSS1 P07477 2/20 0.32
CTSG P08311 2/20 0.32
CTRB1 P17538 2/20 0.32
CMA1 P23946 2/20 0.32
ADRB2 P07550 1/20 0.31
ADRB1 P08588 1/20 0.31
CYP2D6 P10635 1/20 0.31
NFKB1 P19838 1/20 0.31
HIF1A Q16665 1/20 0.31
BLM P54132 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21708761 0.84 NISCH (0.35) ALDH1A1GAATAS1R3TAS1R1CASP1
SCHEMBL21708788 0.81 ALDH1A1 (0.42) ALDH1A1CYP3A4GAACNR1CASP1
SCHEMBL21632143 0.78 ALDH1A1 (0.43) ALDH1A1CYP3A4GAACNR1CASP1
SCHEMBL21708797 0.71 CASP1 (0.33) ALDH1A1CYP3A4GAATAS1R3TAS1R1
SCHEMBL28016548 0.69 ALDH1A1 (0.41) ALDH1A1CYP3A4GAACNR1ADRB2
SCHEMBL27944710 0.66 ADRB2 (0.40) ALDH1A1CYP3A4GAACNR1CASP1
SCHEMBL21708646 0.66 NISCH (0.37) ALDH1A1CYP3A4GAATAS1R3TAS1R1
SCHEMBL21708708 0.66 SMN1; SMN2 (0.33) ALDH1A1GAATAS1R3TAS1R1
SCHEMBL14917000 0.66 CNR1 (0.43) ALDH1A1GAACNR1TAS1R3TAS1R1
SCHEMBL14917001 0.66 CNR1 (0.43) ALDH1A1GAACNR1TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed